Risk of cervical cancer death before 30 ‘close to zero’ after HPV vaccine

• Key Takeaways for Clinical Practice
• The HPV vaccination programme introduced in UK schools in 2008 has demonstrated significant real-world effectiveness, with cervical cancer deaths in vaccinated cohorts approaching zero before age 30.
• This evidence supports continued promotion of HPV vaccination to eligible patients and reinforces the importance of high uptake rates in school-based immunisation programmes.
• The study provides reassuring long-term safety and efficacy data that can be used when counselling patients about HPV vaccination and addressing vaccine hesitancy concerns.

A new study finds that hundreds of lives have been saved since school-age girls were offered the HPV jab in 2008.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.